Nao Medical

Nao Medical's Jamaica location in Queens, New York is a REMS-certified facility providing FDA-approved Spravato (esketamine) for eligible adults with treatment-resistant depression and for adults with major depressive disorder experiencing acute suicidal thoughts or actions. Spravato is an esketamine nasal spray that acts on glutamate, offering relief when standard antidepressant treatment has not been enough.

Treatment includes a clinical evaluation, benefits verification, prior authorization support, and monitored in-office dosing followed by an observation period, along with transportation planning for each treatment day.

Eligible patients are paired with a dedicated care manager for authorization, scheduling, and logistics. The Jamaica clinic gives Queens patients an active, accessible Spravato option, accepting major insurance including Medicaid and Medicare.